Crypto_Voyager
vip

Christian Angermayer, the chairman of Germany-based biopharmaceutical company atai Life Sciences (ATAI) announced today that the firm would develop its own bitcoin treasury strategy.


โ€œIn an era of persistent inflation and volatile markets, I find myself asking an important question for biotech companies looking to preserve and optimize the capital they have: Could allocating a portion of treasury cash to bitcoin help preserve, optimize, and even extend a companyโ€™s runway and hence contribute to its success,โ€ Angermayer wrote on Substack.
The company will initially invest $5 million in bitcoin, Angermayer said, while holding enough cash, short-term securities and public equity for operational expenses into 2027.
#TUT Price Rise#
#Crypto ETFs Under Application#
The content is for reference only, not a solicitation or offer. No investment, tax, or legal advice provided. See Disclaimer for more risks disclosure.
  • Reward
  • 1
  • Share
Comment
0/400
Miss_1903vip
ยท 03-21 01:59
HODL Tight ๐Ÿ’ช
Reply0
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate.io app
Community
English
  • ็ฎ€ไฝ“ไธญๆ–‡
  • English
  • Tiแบฟng Viแป‡t
  • ็น้ซ”ไธญๆ–‡
  • Espaรฑol
  • ะ ัƒััะบะธะน
  • Franรงais (Afrique)
  • Portuguรชs (Portugal)
  • Indonesia
  • ๆ—ฅๆœฌ่ชž
  • ุจุงู„ุนุฑุจูŠุฉ
  • ะฃะบั€ะฐั—ะฝััŒะบะฐ
  • Portuguรชs (Brasil)